Condition
RCC clinical trials and research
Research outlook What's coming for Kidney cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 5 RCC clinical trials that are recruiting, at sites in 2 countries (most in United States (4), China (1)). By phase: Phase 1 (2), Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest RCC clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| NEO-811 for advanced or metastatic clear cell kidney cancer | Phase 1 | Duarte, California and 15 other locations | Recruiting | Dec 23, 2025 |
| Evaluating a new CAR T-cell therapy for solid tumors expressing EGFR | Phase 1/2 | Gilbert, Arizona and 9 other locations | Recruiting | Nov 12, 2024 |
| Treatment with SPX-303 for patients with solid tumors | Phase 1 | Phoenix, Arizona and 3 other locations | Recruiting | Feb 14, 2024 |
| Higher dose of cabozantinib for advanced kidney cancer | Phase 2 | Dallas, Texas | Recruiting | Jul 5, 2023 |
| Monitoring kidney cancer using blood tests for DNA changes | — | Nanjing, Jiangsu | Recruiting | Jun 23, 2023 |
All recruiting trials (5)
-
NEO-811 for advanced or metastatic clear cell kidney cancer
This study will try the experimental oral drug NEO-811 in people with locally advanced or metastatic clear cell kidney cancer who have progressed on or refused standard treatments.
-
Evaluating a new CAR T-cell therapy for solid tumors expressing EGFR
This study is testing a new CAR T-cell therapy to see if it can safely help adults with certain solid tumors, like colorectal and lung cancer, that have specific markers.
-
Treatment with SPX-303 for patients with solid tumors
This study is testing a new treatment called SPX-303 for patients with solid tumors that haven't improved with previous therapies to see if it can help them feel better.
-
Higher dose of cabozantinib for advanced kidney cancer
This study is testing whether a higher dose of cabozantinib can help people with advanced kidney cancer who didn’t respond to previous treatment with the same drug.
-
Monitoring kidney cancer using blood tests for DNA changes
This study is testing if blood tests that look for DNA changes can help track kidney cancer in patients before and after surgery.
Related topics
Quick answers
How many RCC clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (4 trials), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.